QUEST DIAGNOSTICS INC
Customers
3
3 federal agencies
Suppliers
1
0 disclosed
Federal obligations
$43.9M
FY2027 · USAspending.gov
Latest period
Dec 31, 2020
10-Q filed 2021-05-13
Suppliers 1
Companies that disclose DGX as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from DGX | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| BNGO Bionano Genomics, Inc. |
Named | — | FY 2020-12-31 | — | Lapsed Last seen 2020-12-31 |
10-Q 2021-05-13 |
As of December 31, 2020, Illumina, and Quest Diagnostics represented 17.3%, and 10.1%, respectively, of the Company’s total accounts receivable balance. | ||||||
Federal contracts 3
Agencies that awarded contracts to this company, from USAspending.gov. Dollars are obligated amounts as reported, not estimates; $55.6M in the latest fiscal year shown per agency.
| Agency | Obligated | Fiscal year | Awards | Trend | Largest award |
|---|---|---|---|---|---|
| Department of Veterans Affairs
Department of Veterans Affairs |
$43.9M | FY 2027 | 37 | $94.0M → $81.3M → $91.4M → $107.9M → $43.9M | 36C25227N0098 |
FY27 TASK ORDER - 10/1/2026 - 6/30/2027 | |||||
| Department of Health and Human Services
Centers for Disease Control and Prevention |
$7.0M | FY 2024 | 52 | $37.3M → $7.0M | 75D30124F00002 |
TEST SURGE AND DATA SHARING MULTIPLE AWARD INDEFINITE DELIVERY INDEFINITE QUANTITY (IDIQ) | |||||
| Department of Justice
Federal Prison System / Bureau of Prisons |
$4.6M | FY 2026 | 392 | $8.3M → $11.7M → $12.0M → $4.6M | 15B30226F00000008 |
QUEST GENERAL LAB TESTING OCTOBER TO DECEMBER 2025 FISCAL YEAR 2026 RP#: 0008-26 TASK ORDER TO COVER 3-MONTH EXTENSION PERIOD OF BPA15BNAS20A00000070: OCTOBER 1, 2025 - DECEMBER 31, 2025. | |||||
Alerts are coming
Get an email when DGX's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.